The effect of APOE genotype on brain levels of oxysterols in young and old human APOE ε2, ε3 and ε4 knock-in mice
- 21 April 2010
- journal article
- research article
- Published by Elsevier BV in Neuroscience
- Vol. 169 (1), 109-115
- https://doi.org/10.1016/j.neuroscience.2010.04.026
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brainNeurobiology of Aging, 2009
- Altered Lipid Metabolism in Brain Injury and DisordersSub-cellular biochemistry, 2007
- LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetesAtherosclerosis, 2007
- High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigsSteroids, 2004
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- Apolipoprotein E: a major piece in the Alzheimer's disease puzzleJournal of Cellular and Molecular Medicine, 2001
- Apo E structure determines VLDL clearance and atherosclerosis risk in miceJCI Insight, 1999
- Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2.JCI Insight, 1998
- Apolipoprotein E and Alzheimer's DiseaseAnnual Review of Neuroscience, 1996
- Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proceedings of the National Academy of Sciences of the United States of America, 1992